Welcome to our dedicated page for Visa SEC filings (Ticker: V), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Visa’s filings don’t just list numbers—they reveal how the world’s largest card network earns fees on every swipe, tap, and click. Yet finding cross-border volume trends or tracking when executives sell shares can feel like searching thousands of lines of legal text. That’s the problem we solve.
Stock Titan’s AI turns dense documents into clear insights. Whether you need a Visa quarterly earnings report 10-Q filing to compare payment volumes, or you’re watching Visa insider trading Form 4 transactions for buying signals, our platform highlights the metrics and footnotes that move the stock. Real-time EDGAR feeds mean every Visa Form 4 insider transactions real-time alert lands in your dashboard within seconds.
Browse every form in one place:
- 10-K: Get the Visa annual report 10-K simplified with AI-driven summaries of client incentives, litigation exposures, and network security investments.
- 10-Q: Dive into quarterly updates—our AI links segment revenue to macro trends for fast Visa earnings report filing analysis.
- 8-K: See Visa 8-K material events explained, from strategic fintech deals to cyber incidents.
- DEF 14A: Understand the Visa proxy statement executive compensation in plain English, including CEO pay versus performance.
- Form 4: Track Visa executive stock transactions Form 4 and spot buying or selling patterns before earnings calls.
Need context? Type a natural question—“understanding Visa SEC documents with AI” or “Where can I find Visa’s quarterly earnings report?”—and our engine serves the answer, complete with citations. Complex disclosures made clear, updated the moment Visa files.
On 30 June 2025, Wintrust Financial Corp. (WTFC) director Brian A. Kenney reported the acquisition of 420 common shares under the company’s Director’s Deferred Fee and Stock Plan, as disclosed in a Form 4 filing. The shares were credited at a price of $112.46, increasing Kenney’s direct beneficial ownership to 11,214 WTFC shares. The transaction is coded “A,” indicating an award rather than an open-market purchase, and no derivative securities were involved. While routine in nature, the filing slightly increases insider ownership and may be viewed as a signal of continued alignment between the director and shareholder interests.
SpringWorks Therapeutics, Inc. (NASDAQ: SWTX) filed seven Post-Effective Amendments on Form S-8 to deregister all unsold shares previously registered for issuance under its 2019 employee equity plans. The action follows the closing of its merger with Merck KGaA, Darmstadt, Germany on 1 July 2025, under which SpringWorks became a wholly owned subsidiary of Merck through EMD Holdings Merger Sub, Inc.
The amendments cover the following historical S-8 registrations:
- Reg. Nos. 333-234365, 333-237350, 333-253531, 333-262996, 333-270096, 333-277380 and 333-285076.
- In aggregate, these filings had registered tens of millions of common shares for the 2019 Stock Option & Incentive Plan, the Amended & Restated 2019 Equity Incentive Plan and the 2019 Employee Stock Purchase Plan.
Because the company is now private, SpringWorks has terminated all offerings under these plans. Consistent with undertakings in each registration statement, any securities that remained unsold as of the merger date are withdrawn from registration. The filing is signed on behalf of the company by Secretary Michael MacDougall and relies on Rule 478 of the Securities Act to omit additional signatures.
The amendments are largely administrative, signalling the end of SpringWorks’ status as an independent public issuer and the cessation of share issuance under its legacy equity compensation and ESPP programmes.